| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $7.9M | — | +10.3% |
| SG&A Expense | $4.7M | — | +3.9% |
| Operating Income | -$12.7M | — | -7.8% |
| Pre-tax Income | -$12.5M | — | -12.7% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$12.5M | — | -12.7% |
| EPS (Basic) | -$0.32 | — | -14.3% |
| EPS (Diluted) | -$0.32 | — | -14.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.1M | +38.5% | -82.4% |
| Short-term Investments | $9.0M | -54.9% | -30.0% |
| Current Assets | $18.6M | -31.5% | -70.5% |
| Total Assets | $19.4M | -31.4% | -70.0% |
| Current Liabilities | $10.4M | +26.8% | +95.6% |
| Total Liabilities | $10.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.6M | — | +6.8% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $10.9M | — | +185.1% |
| Financing Cash Flow | -$72K | — | — |
| Free Cash Flow | -$8.6M | — | +6.9% |
| +87.7% |
| Stockholders' Equity | $9.0M | -55.0% | -84.8% |